Methods for identifying modulators of tumor necrosis factor receptors
US9081017B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Apr 11, 2006 |
| Grant date | Jul 14, 2015 |
| Priority date | — |
| Expiry date | Nov 28, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/347
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the identification and characterization of specific cellular responses which are associated with tumor necrosis factor receptor 1 (TNFR1) and tumor necrosis factor receptor 1 (TNFR2). Selective modulation of these tumor necrosis factor receptors (TNFRs) Selective modulations of these responses may be useful in the promotion or inhibition of cell growth, for example, in the treatment of disease conditions, including cardiovascular and kidney diseases. Therapeutic methods employed selective TNFR1 and TNFR2 modulators are provided, along with screening methods for the identification of selective TNFR1 and TNFR2 modulators useful in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.